Other
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation
Xylem Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation decreased by 333.0% to -$671M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 982.3%, from -$62M to -$671M. Over 2 years (FY 2023 to FY 2025), Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation shows an upward trend with a 118.5% CAGR.
Analysis
StatementIncome Statement
SectionOther
First reportedQ1 2018
Last reportedQ1 2026Apr 28, 2026
Metric ID:
other_cash_cash_equivalents_restricted_cash_and_restrict_8b4577Historical Data
17 periods
| Q3 '21 | Q1 '22 | Q2 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$585M | -$232M | -$4M | -$242M | -$107M | -$129M | -$3M | $314M | -$72M | -$132M | $174M | $132M | -$62M | $111M | $21M | $288M | -$671M |
| QoQ Change | — | +60.3% | +98.3% | <-999% | +55.8% | -20.6% | +97.7% | >999% | -122.9% | -83.3% | +231.8% | -24.1% | -147.0% | +279.0% | -81.1% | >999% | -333.0% |
| YoY Change | — | — | — | — | +53.9% | <-999% | — | +229.8% | +32.7% | -2.3% | >999% | -58.0% | +13.9% | +184.1% | -87.9% | +118.2% | -982.3% |
Range-$671M – $314M
CAGR+3.5%
Avg YoY Growth+189.8%
Median YoY Growth+23.3%
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation at Other Companies
Frequently Asked Questions
- What is Xylem's cash, cash equivalent, restricted cash, and restricted cash equivalent, period increase (decrease), including exchange rate effect and discontinued operation?
- Xylem (XYL) reported cash, cash equivalent, restricted cash, and restricted cash equivalent, period increase (decrease), including exchange rate effect and discontinued operation of -$671M in Q1 2026.
- How has Xylem's cash, cash equivalent, restricted cash, and restricted cash equivalent, period increase (decrease), including exchange rate effect and discontinued operation changed year-over-year?
- Xylem's cash, cash equivalent, restricted cash, and restricted cash equivalent, period increase (decrease), including exchange rate effect and discontinued operation decreased by 982.3% year-over-year, from -$62M to -$671M.
- What is the long-term trend for Xylem's cash, cash equivalent, restricted cash, and restricted cash equivalent, period increase (decrease), including exchange rate effect and discontinued operation?
- Over 2 years (2023 to 2025), Xylem's cash, cash equivalent, restricted cash, and restricted cash equivalent, period increase (decrease), including exchange rate effect and discontinued operation has grown at a 118.5% compound annual growth rate (CAGR), from $75M to $358M.